Results of interferon treatment in children with chronic hepatitis B

Romanian Journal of Gastroenterology

Volumn 11, Issue 4, 2002, Pages 285-290

  Grigorescu Sido, Paula ^a,b   Cǎlin, Lazǎr ^a   Manasia, Rodica ^a   Ştefan, Mireştean ^a   Creţ, Victoria ^a   Skorka, Cristina ^a   Grigorescu Sido, Anca ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinica Pediatrie III   (Romania)

Author keywords

Children; Chronic hepatitis B; HBeAg HBeAb; HBsAg HBsAb seroconversion; Interferon treatment

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHRONIC HEPATITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; TREATMENT OUTCOME; VIRUS REPLICATION;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INTERFERON-ALPHA; MALE; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0036929166     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Vargas V, Esteban R. Hepatitis B: Clinical manifestations. Diagnosis and management. Tim Top Med 2001: 1-12.
2. Mullhaupt B, Renner EL. Therapy of chronic hepatitis B and C. Schweiz Rundsch Med Prax 1999; 88: 619-632.
3. Grigorescu M, Pascu O, Strǎin R et al. Hepatitele cronice virale - Recomandǎri terapeutice. Rom J Gastroenterol 1999; 8: 295-300.
4. Oproiu AI, Ioniţǎ A, Pascu O, Grigorescu M, Chira C. Indicaţiile, contraindicaţiile şi monitorizarea tratamentului antiviral în hepatitele cronice. Consfǎtuirea de Consens Naţional, Tg.Mureş, România, 6-7 iunie 1997. Rom J Gastroenterol 1998; 7: 14-21.
5. Yuce A, Kocak N, Ozen H, Gurakan F. Prolonged interferon alpha treatment in children with chronic hepatitis B. Ann Trop Paediatr 2001; 21: 77-80.
6. Barbera C, Barbolotti F. Crivellaro C et al. Recombinant interferon alpha 2a hastens the rate of HBe Ag clearance in children with chronic hepatitis B. Hepatology 1994; 20: 287-290.
7. Gurakan F, Kocak N, Ozen H, Yuce A. Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection. Pediatr Infect Dis J 2000; 19: 52-56.
8. Sokale M, Wirth S, Goyens P et al. Interferon-alpha 2b therapy in children with chronic hepatitis B. Gut 1993; 34(2 suppl.): 587-590.
9. Vajro P, Tedesco M, Fontanella A et al. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone accelerates termination of active viral replication in children witl chronic hepatitis B infection. Pediatr Infect Dis J 1996; 15: 223-231.
10. Bruguera M, Amati L, Garcia O et al. Treatment of chronic hepatitis B in children with recombinant alpha interferon. Different response according to age at infection. J Clin Gastroenterol 1993; 17: 296-299.
11. Narkewicz MR, Smith D, Silverman A et al. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment. J Pediatr 1995; 127: 815-818.
12. Cullu F, Tumay F, Kutlut T et al. Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon. Gastroenterol Clin Biol 1995; 19: 53-57.
13. Torre D, Tambini R. Interferon-alpha therapy for chronic hepatitis B in children: A meta-analysis. Clin Infect Dis 1996; 23: 131-137.
14. Bortolotti F, Jara P, Barbeta C et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46: 715-718.
15. Miu N, Burac L, Gheban D et al. Evaluation of interferon and hepatitis B vaccine-therapy in chronic hepatitis B in children. Rom J Gastroenterol 1999; 8: 3-7.
16. Moraru E, Goţia S, Coman G et al. Probleme practice ale tratamentului cu interferon alfa în hepatita cronicǎ activǎ postviralǎ la copii. Rev Rom Pediatr 1977; 3: 352-356.
17. Yuen MF, Hui CK, Cheng CC, Wu CH, Lay P, Lay CL. Long-term follow-up of interferon alpha treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of chirrhosis-related complications. Hepatology 2001; 34: 139-145.
18. Hwang SJ, Lu RH, Wang YJ et al. Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon. Zhoughua Yi Xue Za Zhi 2000; 63: 1-7.
19. Wong DK, Cheung AM, O'Rourke K. Effect of alpha interferon treatment in patients with hepatitis B e entigen positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312-323.
20. Simon K, Rotter K, Zalewska M, Fladzsy A. HBV-DNA level in blood serum as a predictor of good response to therapy with interferon-alpha-2b of patients with chronic hepatitis B. Med Sci Monit 2000; 6: 971-975.
21. Stajic M, Dojcinov D, Golubovic G, Milanovic B. Therapy of chronic hepatitis B with recombinant alpha-2 interferon (Roferon A-Roche). Rom J Gastroenterol 1994; 3: 9-12.
22. Niederau C, Heintgest T, Lange S et al. Long term follow-up of HBe Ag-positive patients treated with interferon alpha for chronic hepatitis B. N Engl J Med 1996; 334: 1422-1427.
23. Techapaitoon S. Efficacy of high dose interferon-alpha treatment of chronic hepatitis B J Med Assoc Thai 1999; 82: 1118-1126.
24. Martin P, Hann HW, Westerberg S et al. Interferon-alpha - 2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: A prospective controlled trial. Dig Dis Sci 1998; 43: 875-879.
25. Mazzella G, Saracco G, Festi D et al. Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial. Am J Gastroenterol 1999; 94: 2246-2250.
26. Martin-Vivaldi R, Nogueras F, Vignote ML et al. Multicenter retrospective study of response to interferon in chronic hepatitis B. Rev Esp Enferm Dig 2000; 92: 561-572.
27. Yuen MF, Lai CL. Treatment of chronic hepatitis B. Lancet Infect Dis 2001; 1: 232-241.
28. Chang MH, Hsu HY, Miy H et al. The significance of spontaneous hepatitic Be antigen seroconversion in childhood: With special emphasis on the clearance of hepatitic Be antigen before 3 years of age. Hepatology 1995; 22: 1387-1391.
29. Hsu HY, Chang MH, Lee C et al. Spontaneous loss af HBs antigen in children with chronic hepatitis B virus infection. Hepatology 1992; 15: 382-386.